JENNIFER MCCARSON: Open Payments
NPI 1962009209 · SENECA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$239 in 9 payments from 5 companies in 2025. Trend: 2023 $244 · 2024 $140 · 2025 $239
Food & beverage: $239
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $93 |
| Melinta Therapeutics, LLC | 3 | $63 |
| Insmed, Inc. | 2 | $43 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
Products named: Rezzayo, Epclusa, Arikayce, PIFELTRO, NUZYRA.
Industry payments across SC — which companies pay providers there.
